The
integration of ethical analysis in Health Technology Assessment (HTA) has
proven difficult to implement even though it is explicitly recognized as an
important component of such assessments in HTA literature. When compared to the
standardized scientific method for systematic reviews in HTA, the diversity of ethical
analysis has been characterized as a fundamental barrier to the integration of
ethics. The present paper aims to identify the theoretical and practical
differences between the approaches underpinning ethical analysis in HTA and
clarify the reasons for such diversity. Our systematic review of HTA literature
pertaining to the barriers to the integration of ethics in HTA identified nine
ethical approaches: Principlism, Casuistry, Coherence Analysis, Wide Reflective
Equilibrium, Axiology, the Socratic approach, the Triangular model,
Constructive Technology Assessment and Social Shaping of Technology. Citations
pertaining to each approach were extracted and categorized according to three
constitutive components of ethical argumentation established in a previous
research evaluating nanotechnologies: i) the disciplinary foundation that
grounds the validity of the ethical evaluation, ii) the characteristics of such
evaluation, iii) the operational process involved in applying it to a
particular case (i.e., its practical reasoning). This comparison shows that, 1) the
difference between these approaches rests primarily on their disciplinary
foundation (rooted in philosophy, philosophy/theology, or sociology), 2) their
complexity can be observed in the distinct characteristics of ethical
evaluation deriving from their differing disciplinary foundation, and 3)
although four different types of operationalization procedure were identified,
little information was available in regards to the practical reasoning associated
with these approaches.
References
[1]
Assasi, N., Schwartz, L., Tarride, J. E., Campbell, K., & Goeree, R. (2014). Methodological Guidance Documents for Evaluation of Ethical Considerations in Health Technology Assessment: A Systematic Review. Expert Review of Pharmacoeconomics & Outcomes Research, 14, 203-220. https://doi.org/10.1586/14737167.2014.894464
[2]
Assasi, N., Schwartz, L., Tarride, J. E., O’Reilly, D., & Goeree, R. (2015). Barriers and Facilitators Influencing Ethical Evaluation in Health Technology Assessment. International Journal of Technology Assessment in Health Care, 31, 113-123.
https://doi.org/10.1017/S026646231500032X
[3]
Assasi, N., Tarride, J. E., O’Reilly, D., & Schwartz, L. (2016). Steps toward Improving Ethical Evaluation in Health Technology Assessment: A Proposed Framework. BMC Medical Ethics, 17, 34. https://doi.org/10.1186/s12910-016-0118-0
[4]
Béland, J. P., Patenaude, J., Legault, G. A., Boissy, P., & Parent, M. (2011). The Social and Ethical Acceptability of NBICs for Purposes of Human Enhancement: Why Does the Debate Remain Mired in Impasse? Nanoethics, 5, 295-307.
https://doi.org/10.1007/s11569-011-0133-z
[5]
Bellemare, C. A. et al. (2018). Ethics in Health Technology Assessment: A Systematic Review. International Journal of Technology Assessment in Health Care, 34, 447-457.
https://doi.org/10.1017/S0266462318000508
[6]
Bombard, Y., Abelson, J., Simeonov, D. & Gauvin, F. P. (2011). Eliciting Ethical and Social Values in Health Technology Assessment: A Participatory Approach. Social Science & Medicine, 73, 135-144. https://doi.org/10.1016/j.socscimed.2011.04.017
[7]
Braunack-Mayer, A. J. (2006). Ethics and Health Technology Assessment: Handmaiden and/or Critic? International Journal of Technology Assessment in Health Care, 22, 307-312. https://doi.org/10.1017/S0266462306051191
[8]
Campbell Black, H. (2017). The Law Dictionary. http://thelawdictionary.org/ethical-issue/
[9]
Daniels, N., & van der Wilt, G. J. (2016). Health Technology Assessment, Deliberative Process, and Ethically Contested Issues. International Journal of Technology Assessment in Health Care, 32, 10-15. https://doi.org/10.1017/S0266462316000155
[10]
European Network for Health Technology Assessment (EUnetHTA) (2016). Joint Action 2, Work Package 8: HTA Core Model.
http://www.htacoremodel.info/BrowseModel.aspx
[11]
Fletcher, J. F. (1966). Situation Ethics: The New Morality. Philadelphia, PA: Westminster Press.
[12]
Hofmann, B. (2005a). On Value-Judgments and Ethics in Health Technology Assessment. Poiesis und Praxis, 3, 277-295. https://doi.org/10.1007/s10202-005-0073-1
[13]
Hofmann, B. (2005b). Toward a Procedure for Integrating Moral Issues in Health Technology Assessment. International Journal of Technology Assessment in Health Care, 21, 312-318. https://doi.org/10.1017/S0266462305050415
[14]
Hofmann, B. (2013). Health Technology Assessment—Science or Art? GMS Health Technology Assessment, 9, 1-8.
[15]
Hofmann, B. (2014). Why Not Integrate Ethics in HTA: Identification and Assessment of the Reasons. GMS Health Technology Assessment, 10, Doc04.
[16]
Hofmann, B. et al. (2015). Integrating Ethics in Health Technology Assessment: Many Ways to Rome. International Journal of Technology Assessment in Health Care, 31, 131-137. https://doi.org/10.1017/S0266462315000276
[17]
Hofmann, B. M. (2008). Why Ethics Should Be Part of Health Technology Assessment. International Journal of Technology Assessment in Health Care, 24, 423-429.
[18]
Hofmann, B., Droste, S., Oortwijn, W., Cleemput, I., & Sacchini, D. (2014). Harmonization of Ethics in Health Technology Assessment: A Revision of the Socratic Approach. International Journal of Technology Assessment in Health Care, 30, 3-9.
https://doi.org/10.1017/S0266462313000688
[19]
Jonsen, A. R., & Toulmin, S. E. (1988). The Abuse of Casuistry: A History of Moral Reasoning. Oakland, CA: University of California Press.
[20]
Legault, G. A. (2014). Redéfinir la philosophie à l’ère de la technoscience: La raison pratique. In A. Lacroix (Ed.), Quand la philosophie doit s’appliquer (p. 294). Paris, France: Hermann Philosophie.
[21]
Legault, G. A. et al. (2018). Revisiting the Fact/Value Dichotomy: A Speech Act Approach to Improve the Integration of Ethics in Health Technology. Open Journal of Philosophy, 8, 578-593. https://doi.org/10.4236/ojpp.2018.85042
[22]
Legault, G. A., Patenaude, J., Béland, J. P., & Parent, M. (2013). Nanotechnologies and Ethical Argumentation: A Philosophical Stalemate? Open Journal of Philosophy, 3, 15-22. https://doi.org/10.4236/ojpp.2013.31004
[23]
Lehoux, P., & Williams-Jones, B. (2007). Mapping the Integration of Social and Ethical Issues in Health Technology Assessment. International Journal of Technology Assessment in Health Care, 23, 9-16. https://doi.org/10.1017/S0266462307051513
[24]
Liberati, A., Sheldon, T. A., & Banta, H. D. (1997). EUR-ASSESS Project Subgroup Report on Methodology: Methodological Guidance for the Conduct of Health Technology Assessment. International Journal of Technology Assessment & Health Care, 13, 186-219.
https://doi.org/10.1017/S0266462300010369
[25]
Lysdahl, K. B. et al. (2016). Ethical Analysis in HTA of Complex Health Interventions. BMC Medical Ethics, 17, 16. https://doi.org/10.1186/s12910-016-0099-z
[26]
Park, S. Y., Kwon, I., & Oh, I. H. (2016). Burden of Disease Study and Priority Setting in Korea: An Ethical Perspective. Journal of Korean Medical Science, 31, S108-S113.
https://doi.org/10.3346/jkms.2016.31.S2.S108
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=27775247
[27]
Patenaude, J. et al. (2015). Framework for the Analysis of Nanotechnologies’ Impacts and Ethical Acceptability: Basis of an Interdisciplinary Approach to Assessing Novel Technologies. Science and Engineering Ethics, 21, 293-315.
https://doi.org/10.1007/s11948-014-9543-y
[28]
Patenaude, J., Legault, G. A., Béland, J. P., Parent, M., & Boissy, P. (2011). Moral Arguments in the Debate over Nanotechnologies: Are We Talking Past Each Other? Nanoethics, 5, 285-293. https://doi.org/10.1007/s11569-011-0132-0
[29]
Reuzel, R. et al. (2004). Ethics and HTA: Some Lessons and Challenges for the Future. Poiesis & Praxis, 2, 247-256. https://doi.org/10.1007/s10202-003-0054-1
[30]
Reuzel, R. P., van der Wilt, G. J., ten Have, H. A. M. J., & de Vries Robbé, P. F. (1999). Reducing Normative Bias in Health Technology Assessment: Interactive Evaluation and Casuistry. Medicine, Health Care & Philosophy, 2, 255-263.
https://doi.org/10.1023/A:1009963018813
[31]
Saarni, S. I. et al. (2008). Ethical Analysis to Improve Decision-Making on Health Technologies. Bulletin of the World Health Organization, 86, 617-623.
https://doi.org/10.2471/BLT.08.051078
[32]
Saarni, S. I., Braunack-Mayer, A., Hofmann, B., & van der Wilt, G. J. (2011). Different Methods for Ethical Analysis in Health Technology Assessment: An Empirical Study. International Journal of Technology Assessment in Health Care, 27, 305-312.
https://doi.org/10.1017/S0266462311000444
[33]
Sacchini, D., Virdis, A., Refolo, P., Pennacchini, M., & Carrasco de Paula, I. (2009). Health Technology Assessment (HTA): Ethical Aspects. Medicine, Health Care & Philosophy, 12, 453-457. https://doi.org/10.1007/s11019-009-9206-y
[34]
WHO (2019). HTA Definition.
https://www.who.int/health-technology-assessment/about/Defining/en/
[35]
WHO-HTA (2017). WHO: Medical Devices.
http://www.who.int/medical_devices/assessment/en/